The consideration for the Bedrocan transaction was
35,202,818 shares issued at a value of $1.64 per share which totaled $57,733,000 less cash acquired of $900,000.
That was a good deal for sure! Just saying that those shares might have had a market value of $1.64 around that time - but they were ultimately worth much more than that